Posts tagged with 'report'
Market for Clinical Trial Services to Grow 20%Read the rest of this entry »
Clinical trial services are projected to grow at an annual rate of 12% over the next three years, according to a projection from The Business Research Company. That's a 20% increase over the previous few years.
The report says the growth in outsourcing to contract research organizations (CROs) is the result of cost-cutting by pharmaceutical and biotechnology companies, which has led many of them to outsource parts of their drug …
Drug Companies Making Millions From Off-Label Use of Orphan DrugsCharging that orphan drugs "have become a lucrative business opportunity for pharmaceutical companies," a new report suggests drug makers are gaming a system intended to spur the development of treatments that would not otherwise be profitable.Read the rest of this entry »
Funded by the insurance lobby AHIP (American Health Insurance Plans), the report says pharmaceutical companies are benefiting from the tax advantages, market exclusivity and clinical subsidies provided by the Orphan Drug Act. But many …
Pharma's Awareness Campaigns Shifting Away From MarketingWhether or not you recognized it for what it is, all of us have been exposed to disease state awareness campaigns. Those are those ads or commercials that may never mention a brand or a company, instead they discuss a certain disease or illness or condition and most often recommend you consult a doctor.Read the rest of this entry »
When they are funded by a pharmaceutical company, the goal is to raise public consciousness about …
Here's How Big the Tech Industry Really IsThe tech industry in America is big. Everyone knows that. But how big is big?Read the rest of this entry »
- Its payroll was $654 billion in 2014, a sum bigger than the entire GDP of countries like Belgium, Austria, the United Arab Emirates and Sweden.
- 6.5 million workers are employed in the industry. They make up 5.7% of the U.S. workforce. And those are only the W-2 and 1099 professionals.
- Another million sole proprietors and …
Fitch Gives High Grades to Largest Alternative Investment ManagersRead the rest of this entry »
In a special report -- U.S. Alternative Investment Managers: An Industry Update -- Fitch Ratings examined the financial condition and outlook of the 7 largest managers pronouncing them sound while cautioning about the "elevated levels of uncalled investment capital, or dry powder."
"With more capital chasing fewer deals, significant fund underperformance is possible if competition drives prices up further," said Meghan Neenan, Senior Director, Financial Institution at Fitch Ratings and …
Orphan Drug Sales Forecast to Grow 12% AnnuallyOrphan drug sales are forecast to total $178 billion through 2020, growing 11.7% annually over the five years, a rate almost double that of overall prescription drugs.Read the rest of this entry »
EvaluatePhama's new report on orphan drugs predicts that by 2020, they will account for a fifth of all prescription drug sales (excluding generics).
Defined as "a pharmaceutical product aimed at rare diseases or disorders," the number of these drugs available in the market …
Biotech Party Continued On At Mid-YearBiotech and pharmaceuticals -- sometimes called biopharma -- had a strong first half of 2015. With few worries about tax law changes, a crop of new drug approvals, and investors pushing stock values ever-higher, Evaluate Pharma says it magnified "the view that the biotech party is never going to end."Read the rest of this entry »
The Pharma and Biotech Half-Year Review from EP Evaluate said most of the financial measures for the sector were strongly …
New Reports Will Give Public Insight Into New Drug Costs, EffectivenessThe Institute for Clinical and Economic Review said it will soon begin releasing reports to the public on new high-impact drugs that will be an analysis of their clinical effectiveness, their cost, and the potential economic impact they'll have on the healthcare system.Read the rest of this entry »
The Institute says it expects to issue between 15 and 20 reports on the value of new drugs at about the same time the Food and Drug …
Hedge Funds Gain As CTAs Turn NegativePreqin's April Hedge Fund Performance Benchmarks report shows All Strategy Funds have a better return so far this year than other funds tracked by the alternative assets data and research firm.Read the rest of this entry »
These single manager funds booked 4.23% since the beginning of the year. For the 12 months, the return was 7.2%.
CTA funds , which booked 12% for the 12 months, turned negative 1.65% in April, after booking .64 the …
Alternative Asset Funds Near $7 Trillion Thanks to Hedge Fund GrowthRead the rest of this entry »
Global alternative asset funds came within a whisker of hitting $7 trillion under management in 2014. According to the just released Prequin 2015 Global Alternatives Reports the funds grew by $690 billion last year, bringing total assets …![endif]-->!--[if>![endif]-->!--[if>![endif]-->!--[if>